Heparanase expression in primary and metastatic pancreatic cancer

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4655-4659

  Koliopanos, Alexander ^a   Friess, Helmut ^a   Kleeff, Jörg ^a   Shi, Xin ^a   Liao, Quan ^a   Pecker, Iris ^b   Vlodavsky, Israel ^c   Zimmermann, Arthur ^b   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b InSight Ltd   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARANASE; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL INVASION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CHRONIC DISEASE; FEMALE; GLUCURONIDASE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PANCREATITIS; RNA, MESSENGER;

EID: 0035875082     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cancer statistics, 1997
2. Role of growth factors in pancreatic cancer
3. Tumor-suppressive pathways in pancreatic carcinoma
4. bax, but not bcl-2, influences the prognosis of human pancreatic cancer
5. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer
6. Heparanase: Breaking down barriers in tumors
7. Proteoglycans: Structures and interactions
8. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes
9. Molecular architecture of basement membranes
10. Proteoglycans as modulators of growth factor activities
11. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor
12. Extracellular sequestration and release of fibroblast growth factor: A regulatory mechanism?
13. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer
14. Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers
15. Real time quantitative PCR
16. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
17. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: Evidence for its role in colonic tumorigenesis
18. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
19. Changing views of the role of matrix metalloproteinases in metastasis
20. Degradation of basement membrane by prostate tumor heparanase
21. Heparanases and tumor metastasis
22. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
23. Heparanase: A key enzyme involved in cell invasion
24. Production of heparanase by normal and neoplastic murine B-lymphocytes
25. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma
26. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase
27. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases
28. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides
29. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
30. Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation
31. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
32. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas
33. Increased expression of keratinocyte growth factor in human pancreatic cancer